
Please try another search
The U.S. Federal Trade Commission (FTC) is looking into whether baby-formula makers, including Abbott Laboratories (NYSE:ABT), Reckitt Benckiser (OTC:RBGLY), and Nestlé (OTC:NSRGY) colluded on bids for state contracts, the Wall Street Journal reports.
The regulator is reportedly investing whether baby-formula producers have “engaged in collusion or coordination with any other market participant regarding the bidding” for state contracts.
The WSJ report cites FTC’s documents published in April.
Other agencies also launched probes in recent months, including the Justice Department.
In January, the FTC approached Abbott and asked for information about bidding for the state infant-formula supply contracts.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.